首页> 美国卫生研究院文献>Nutrition Metabolism >Plasma bile acids are not associated with energy metabolism in humans
【2h】

Plasma bile acids are not associated with energy metabolism in humans

机译:血浆胆汁酸与人体能量代谢无关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bile acids (BA) have recently been shown to increase energy expenditure in mice, but this concept has not been tested in humans. Therefore, we investigated the relationship between plasma BA levels and energy expenditure in humans. Type 2 diabetic (T2DM) patients (n = 12) and gender, age and BMI-matched healthy controls (n = 12) were studied before and after 8 weeks of treatment with a BA sequestrant. In addition, patients with liver cirrhosis (n = 46) were investigated, since these display elevated plasma BA together with increased energy expenditure. This group was compared to gender-, age- and BMI-matched healthy controls (n = 20). Fasting plasma levels of total BA and individual BA species as well as resting energy expenditure were determined. In response to treatment with the BA sequestrant, plasma deoxycholic acid (DCA) levels decreased in controls (-60%, p < 0.05) and T2DM (-32%, p < 0.05), while chenodeoxycholic acid (CDCA) decreased in controls only (-33%, p < 0.05). Energy expenditure did not differ between T2DM and controls at baseline and, in contrast to plasma BA levels, was unaffected by treatment with the BA sequestrant. Total BA as well as individual BA species did not correlate with energy expenditure at any time throughout the study. Patients with cirrhosis displayed on average an increase in energy expenditure of 18% compared to values predicted by the Harris-Benedict equation, and plasma levels of total BA (up to 12-fold) and individual BA (up to 20-fold) were increased over a wide range. However, neither total nor individual plasma BA levels correlated with energy expenditure. In addition, energy expenditure was identical in patients with a cholestatic versus a non-cholestatic origin of liver disease while plasma total BA levels differed four-fold between the groups. In conclusion, in the various (patho)physiological conditions studied, plasma BA levels were not associated with changes in energy expenditure. Therefore, our data do not support an important role of circulating BA in the control of human energy metabolism.
机译:胆汁酸(BA)最近被证明会增加小鼠的能量消耗,但是这一概念尚未在人体中得到验证。因此,我们研究了血浆中BA水平与人体能量消耗之间的关系。在用BA螯合剂治疗8周之前和之后,研究了2型糖尿病(T2DM)患者(n = 12)以及性别,年龄和与BMI匹配的健康对照(n = 12)。此外,还对肝硬化患者(n = 46)进行了研究,因为这些患者血浆血浆BA升高且能量消耗增加。将该组与性别,年龄和体重指数匹配的健康对照进行比较(n = 20)。测定总BA和单个BA种类的空腹血浆水平以及静息能量消耗。响应BA螯合剂的治疗,对照组中血浆脱氧胆酸(DCA)水平降低(-60%,p <0.05)和T2DM(-32%,p <0.05),而鹅去氧胆酸(CDCA)仅在对照组中降低(-33%,p <0.05)。 T2DM与对照组在基线时的能量消耗没有差异,并且与血浆BA水平相比,不受BA螯合剂处理的影响。在整个研究过程中,总BA以及单个BA物种与能量消耗均不相关。与Harris-Benedict方程预测的值相比,肝硬化患者平均显示出能量消耗增加了18%,血浆总BA(最多12倍)和单个BA(最多20倍)的血浆水平增加了范围广泛。但是,总血浆BA水平或个体血浆BA水平均与能量消耗无关。此外,患有胆汁淤积性肝炎和非胆汁淤积性肝病的患者的能量消耗是相同的,而两组之间血浆总BA水平却相差四倍。总之,在研究的各种(病理)生理条件下,血浆BA水平与能量消耗的变化无关。因此,我们的数据不支持循环BA在控制人类能量代谢中的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号